Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2017-05-11 Notice of Dividend Amou…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Update - Dividend/Distribution - RMD 4 pages 34.8KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and provides detailed information about a dividend payment, including the dividend amount, currency, record date, payment date, withholding tax rates, and exchange rates. It updates a previous announcement regarding the foreign exchange rate for the dividend. The content focuses exclusively on dividend details and payment logistics rather than financial results or broader company performance. The document length is 6512 characters, which is sufficient to contain substantive dividend information rather than just a brief announcement. Therefore, this document fits the category of a Notice of Dividend Amount, which announces dividend amounts, payment dates, and related details for shareholders.
2017-05-11 English
Appendix 3B 8 pages 363.0KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B' and is described as a 'New issue announcement, application for quotation of additional securities and agreement.' It contains detailed information about the issuance of securities, including the number of securities issued, class of securities, issue price, purpose of the issue, and dividend policy. The document references ASX rules and compliance requirements related to securities issuance. This type of document is a formal announcement related to capital raising or changes in capital structure, specifically the issuance of new shares or securities. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail confirm it is not a brief announcement or a report publication announcement but a substantive filing about share issuance.
2017-04-30 English
Form 10Q for QTR ended March 31, 2017 44 pages 229.0KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and explicitly states it is a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934' for the quarterly period ended March 31, 2017. It contains detailed unaudited condensed consolidated financial statements, including balance sheets, income statements, comprehensive income, cash flows, and notes to the financial statements. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full quarterly report, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2017
2017-04-30 English
ResMed Announces Results for the Third Quarter of FY 2017 7 pages 331.7KB
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of financial results for the third quarter of fiscal year 2017 by ResMed Inc. It includes comprehensive financial data such as revenue, net income, earnings per share, operating expenses, and segment performance. It also discusses non-GAAP measures, cash flow, and dividend declarations. The presence of detailed financial statements and analysis for a quarterly period indicates this is a quarterly financial report. The document is about 15,000 characters long, which is consistent with a full interim/quarterly report rather than a brief earnings release or a simple announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2017
2017-04-27 English
Dividend/Distribution - RMD 4 pages 33.5KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about the dividend amount, ex-date, record date, payment date, currency, withholding tax rate, and other dividend-related specifics. It is an announcement informing shareholders about the dividend payment rather than a full financial report or analysis. The content matches the description of a Notice of Dividend Amount filing, which announces dividend amounts, payment dates, and details for shareholders. The document length is about 4849 characters, which is consistent with a detailed announcement but not a full report. Therefore, the appropriate classification is 'Notice of Dividend Amount' (DIV).
2017-04-27 English
ResMed to Announce Third Quarter Fiscal Year 2017 Results 1
Earnings Release Classification · 90% confidence The document is a press release announcing the date and details of an upcoming earnings results announcement for ResMed's third quarter fiscal year 2017. It provides information about the webcast and replay but does not contain any actual financial results or detailed financial data. The document length is short (2237 characters) and it is clearly an announcement of a future earnings release event, not the earnings release itself or a transcript. Therefore, it fits the category of Earnings Release (ER) announcement, but since it does not contain the results, it is best classified as a Regulatory Filing (RNS) as a general announcement. However, given the specific nature of the announcement about earnings results and webcast, the best fitting category is Earnings Release (ER) as it is the initial announcement of quarterly financial results timing and webcast details, which is typical for ER filings. Q3 2017
2017-03-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.